Clinical trial

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

NCT01190826

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE2

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2012-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

ASM-024DRUG

ASM-024 100 mgDRUG

PlaceboDRUG

Sponsors & collaborators

Asmacure Ltéelead sponsor

Mapped research locations

MontrealQuebec, Canada1 HamiltonOntario, Canada1 QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01190826 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.